Biotech Archives - Page 763 of 795

1 minute read

FDA
News

FDA Grants Orphan Drug Designation to Omeros’ MASP-3 Inhibitor OMS906 For Treatment Of Paroxysmal Nocturnal Hemoglobinuria

July 29, 8:45 AM

Omeros Corporation today announced that OMS906 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). OMS906 targets

OMER

1 minute read

AbbVie’s Q2 Sales Marginally Shy Of Wall Street Estimates, Confirms Annual Profit Outlook

By Vandana Singh

July 29, 8:35 AM

AbbVie Inc (NYSE:ABBV) reports Q2 adjusted EPS of $3.37, up 11.2% Y/Y and beating the consensus of $3.33. Overall sales…

ABBV

2 minute read

Adamis Pharmaceuticals Provides Update On Clinical Study Assessing Tempol For The Treatment Of COVID-19

By Benzinga Newsdesk

July 29, 7:31 AM

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today provided an update on the Company's ongoing U.S. Phase 2/3 clinical trial to evaluate the safety and efficacy of Tempol as a treatment for COVID-19. The

ADMP

3 minute read

Apollo Endosurgery Highlights Publication In The Lancet Of Landmark Study For Endoscopic Sleeve Gastroplasty Procedure

By Bill Haddad

July 29, 7:03 AM

Publication of MERIT Study Follows FDA Market Authorization of Apollo ESG™ AUSTIN, TX / ACCESSWIRE / July 29, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally

APEN

1 minute read

AstraZeneca Q2 Highlights: Profits Fall, COVID-19 Vaccine Sales Dip, Lifts Annual Sales Guidance

By Vandana Singh

July 29, 6:04 AM

AstraZeneca Plc (NASDAQ:AZN) Q2 profits fell sharply on ballooning costs linked to its Alexion takeover. The net profit was down…

AZN

2 minute read

Bausch Health To Appeal Expected Court Decision On Xifaxan Patents

By Vandana Singh

July 29, 5:01 AM

Yesterday, Bausch Health Companies Inc (NYSE: BHC) stock closed 50% lower after the reports on the order on patent litigation over Xifaxan (rifaximin).

BHC

3 minute read

Recap Of Thursday’s Biotech Catalysts – End of The Day Summary

By Ragothaman Srinivasan

July 28, 6:38 PM

Cyclerion Therapeutics (NASDAQ:CYCN) announced positive topline data from its clinical study of CY6463 for the treatment of Cognitive…

ACER

1 minute read

FDA
News

ImmunityBio Announces FDA Acceptance Of Biologics License Application For N-803 In BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer Carcinoma In Situ

By Benzinga Newsdesk

July 28, 4:54 PM

The FDA accepted for review a Biologics License Application (BLA) from ImmunityBio, Inc. ((IBRX), for its antibody cytokine fusion protein as a treatment for patients with BCG-unresponsive non-muscle-invasive bladder

IBRX

1 minute read

Gilead’s Biktarvy Demonstrates High Efficacy In HIV/HBV Coinfection Patients

By Vandana Singh

July 28, 3:09 PM

Gilead Sciences Inc (NASDAQ:GILD) announced results reinforcing Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) as a highly efficacious treatment option for HIV, including individuals with…

GILD

2 minute read

Aethlon Medical Highlights Publication Of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding Of Seven COVID-19 Variants

By Bill Haddad

July 28, 2:02 PM

Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today announced the publication of a peer-reviewed

AEMD